100 related articles for article (PubMed ID: 22379878)
1. [Influence of perftoran on pharmacokinetics of hydrophilic drugs].
Pshenkina NN
Eksp Klin Farmakol; 2011; 74(12):23-6. PubMed ID: 22379878
[TBL] [Abstract][Full Text] [Related]
2. [Influence of Perftoran nanoemulsion on blood plasma concentrations of lipophilic drugs].
Pshenkina NN
Eksp Klin Farmakol; 2012; 75(2):30-4. PubMed ID: 22550857
[TBL] [Abstract][Full Text] [Related]
3. [Brain electric activity of animals exposed to perfluorocarbon emulsions].
Vorob'ev VV; Iarkov AV; Kukukshkin NI; Sologub GR; Gal'chenko AA
Patol Fiziol Eksp Ter; 1991; (2):19-23. PubMed ID: 1881700
[TBL] [Abstract][Full Text] [Related]
4. Effect of perftoran on macroglobulin content in the plasma and peritoneal exudate of rats with acute exudative inflammation (peritonitis).
Lykova OF; Romanova TV; Moiseeva LM; Konysheva TV; Grigor'ev EV; Zorin NA
Bull Exp Biol Med; 2004 Oct; 138(4):351-3. PubMed ID: 15665942
[TBL] [Abstract][Full Text] [Related]
5. [Hemorheologic studies on intravenous infusion of perfluorocarbon blood substitute in monkeys (author's transl)].
Ding XC; Jiang HX; Cao WJ; Wang GF; Chen F
Zhongguo Yao Li Xue Bao; 1982 Mar; 3(1):38-41. PubMed ID: 6211902
[No Abstract] [Full Text] [Related]
6. [Perftoran--blood substitute with oxygen transport function].
Golubev AM
Biull Eksp Biol Med; 1998 May; 125(5):484-92. PubMed ID: 9644539
[No Abstract] [Full Text] [Related]
7. [Blood plasma protein adsorption capacity of perfluorocarbon emulsion stabilized by proxanol 268 (in vitro and in vivo studies)].
Sklifas AN; Zhalimov VK; Temnov AA; Kukushkin NI
Biofizika; 2012; 57(2):317-24. PubMed ID: 22594289
[TBL] [Abstract][Full Text] [Related]
8. [The effect of perftoran on the morphofunctional status of the digestive system organs in experimental duodenal ulcer].
Karimov KhIa; Daminov ShN; Khoroshaev VA
Eksp Klin Farmakol; 1999; 62(4):33-6. PubMed ID: 10513333
[TBL] [Abstract][Full Text] [Related]
9. Perftoran as a means modulating the functional activity of liver macrophages.
Kovelenov AY; Mikhal'tsov AN; Malkov AN
Bull Exp Biol Med; 2002 Dec; 134(6):551-3. PubMed ID: 12660835
[TBL] [Abstract][Full Text] [Related]
10. [The immunological effects of perftoran].
Pluzhnikov NN; Lobzin IuV; Kovelenov AIu; Zhelezkova EV; Gusev DA
Eksp Klin Farmakol; 1998; 61(5):34-6. PubMed ID: 9854631
[TBL] [Abstract][Full Text] [Related]
11. Structural and functional characteristics of erythrocyte membranes and their correction with perftoran.
Karmen NB; Milyutina NP; Orlov AA
Bull Exp Biol Med; 2005 May; 139(5):562-4. PubMed ID: 16224549
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics of intranasal and intratracheal pentoxifylline in rabbits.
Adcock KG; Kyle PB; Deaton JS; Olivier JH; Hogan SM
Pharmacotherapy; 2007 Feb; 27(2):200-6. PubMed ID: 17253910
[TBL] [Abstract][Full Text] [Related]
13. [Mechanisms of human plasma proteins adsorption on the surface of perfluorocarbon emulsion stabilized with proxanol 268].
Zhalimov VK; Sklifas AN; Kukushkin NI
Biofizika; 2012; 57(2):308-16. PubMed ID: 22594288
[TBL] [Abstract][Full Text] [Related]
14. Physiological effects of perfluorocarbon blood substitutes.
Lowe KC; Bollands AD
Med Lab Sci; 1985 Oct; 42(4):367-75. PubMed ID: 3908874
[No Abstract] [Full Text] [Related]
15. [The use of perftoran for the lengthening of the period of tolerance to the experimental acute lethal hypoxia (the apnea model)].
Skorik VI; Shilov VV; Sudus AV; Zuev VV
Biull Eksp Biol Med; 1997 Oct; 124(10):477-80. PubMed ID: 9410188
[No Abstract] [Full Text] [Related]
16. [Long term effects of intravenous infusion of fluorocarbon blood substitute in dogs].
Ding XC; Wang BS; Tang QN; Wang GF; Qin YQ; Liu YL
Zhongguo Yao Li Xue Bao; 1985 Dec; 6(4):270-3. PubMed ID: 2945371
[No Abstract] [Full Text] [Related]
17. Effects of biliary obstruction on the penetration of ciprofloxacin and cefotaxime.
Dhalluin-Venier V; Bazin C; Massias L; Farah RB; Boytchev I; Fritsch J; Choury AD; Prat F; Buffet C; Furlan V; Pelletier G
Eur J Gastroenterol Hepatol; 2008 Feb; 20(2):127-30. PubMed ID: 18188033
[TBL] [Abstract][Full Text] [Related]
18. [Influence of a fluorocarbon blood substitute on phagocytic function of the liver and spleen].
Ding XC; Zhang SN; Liu CF; Wang GF; Wang BS
Zhongguo Yao Li Xue Bao; 1983 Sep; 4(3):180-3. PubMed ID: 6228117
[No Abstract] [Full Text] [Related]
19. [Characteristics of enzyme induction in the liver monooxygenase system of rabbits intravenously administered a fluorocarbon emulsion].
Obraztsov VV; Sklifas AA; Kukushkin NI
Farmakol Toksikol; 1989; 52(5):60-3. PubMed ID: 2599081
[TBL] [Abstract][Full Text] [Related]
20. [The use of perftoran in patients with burn shock].
Kligunenko EN; Slinchenkov VV; Leshchev DP
Klin Khir; 2000; (4):41-3. PubMed ID: 10857343
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
